Brussels Region (BE1)
Regional Innovation Performance (2019) Leader -
Total population (2019) 1215290
Population per km² (2017) 7422
Proportion population older 65 year % 13,06%
The region has a population of 1.2 million. In terms of health, the region's strengths lie in its large hospital-hospital hub and the high concentration of people with varied socio-cultural profiles. This provides a breeding ground for clinical trials and collaborations between different scientific disciplines (engineering sciences, life sciences, etc.).
Medical research in the region is recognized in oncology, chronic and neurodegenerative diseases, medical devices and medical engineering. The objective of the strategic field of activity "Personalized Medicine and Wellness" is therefore to capitalize on these assets in order to improve the performance of care and the quality of life of patients. There is a focus on the development of personalized therapies and services, improving the hospital-to-home care chain (e-health) and prevention, by improving the environmental quality of life.
Member ICPerMed? no
Mountain ? Non-mountain
Member Euregha? no
Adriatic-Ionian MacroRegion? no
InnoStars Region? no
Northern Sparsely Populated Area (NSPA)? no
PM region according EC? no
Baltic Sea MacroRegion? no
S3MedTech region? no
Danube MacroRegion? no
S3P4PM region? no
Alpine MacroRegion? no
Regions4PM region? no
Central Europe? no
Council of European BioRegions (CEBR)? yes
1M+Genome initiative? country level member
European Regions Research & Innovation Network (ERRIN)? yes
Vanguard Initiative? no
S3ClusSport member? no
Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); ICT/genomics, health, lifestyle data(infrastructure); Public awareness, patient participation with respect to Personalised Medicine/Personalised Health
NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives:
Q.86 - Human health activities; Q.87 - Residential care activities; Q.88 - Social work activities without accommodation; M.72 - Scientific research and development.
Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS133 - R&D related to Medical Sciences - financed from other sources than GUF.
Policy objective Personalised Medicine/Personalised Health related related to Research and Innovation objectives: G - Public health & security; H.52 - New or improved service processes; H.53 - New or improved service products (commodities or public services); I.54 - New organisational models & social relations that meet social needs; I.59 - Social innovation with regard to health, well-being & elder care.
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Biobank Brussels Health Campus
Digital Innovation Hub:
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
Region represented in : EUREKA/Eurostars/COSME